The National Institutes of Health in September allocated nearly $2 million in grant funding to support six research projects focusing on microRNAs in the brain and their relationship to conditions including schizophrenia, glioblastoma, and Alzheimer's disease.

Dementia

The first grant went to Advanced Genomic Technology, a Louisville, Ky.-based diagnostics firm developing a miRNA-based blood test for determining the risk of mild cognitive impairment, or MCI, converting into Alzheimer's disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.